Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRK vs GSK✓SelectedUSD · GSKMRK vs GSK performance historyLatest closeAs of-0.75%11/17
Stock and ETF performance explorer

MRK vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+102.3%
GSK return
+43.9%
Excess return
+58.3%
Maximum drawdown
-43.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.8%-2.3%+1.6%+0.2%
7D-3.2%-3.0%-0.1%-1.9%
30D-1.8%+0.4%-2.1%-2.0%
3M+6.1%-1.2%+7.3%+6.6%
6M+30.4%+0.9%+29.5%+30.1%
YTD+39.0%+4.0%+35.0%+37.0%
1Y+58.9%+7.3%+51.6%+54.7%
3Y+54.4%+57.1%-2.7%+29.1%
5Y+102.3%+43.0%+59.3%+73.2%
All+102.3%+43.9%+58.3%+73.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling